| 1 |
Di Rosa M, Distefano G, Zorena K, et al. Chitinases and immunity: Ancestral molecules with new functions [J]. Immunobiology, 2016, 221(3): 399-411.
|
| 2 |
Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family [J]. J Biol Chem, 1993, 268(34): 25803-25810.
|
| 3 |
Dela Cruz CS, Liu W, He CH, et al. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses [J]. Cell Host Microbe, 2012,12(1): 34-46.
|
| 4 |
Schmidt IM, Hall IE, Kale S, et al. Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function [J]. J Am Soc Nephrol, 2013, 24(2): 309-319.
|
| 5 |
Xu N, Bo Q, Shao R, et al. Chitinase-3-like-1 promotes M2 macrophage differentiation and induces choroidal neovascularization in neovascular age-related macular degeneration [J]. Invest Ophthalmol Vis Sci, 2019, 60(14): 4596-4605.
|
| 6 |
Bara I, Ozier A, Girodet PO, et al. Role of YKL-40 in bronchial smooth muscle remodeling in asthma [J]. Am J Respir Crit Care Med, 2012, 185(7): 715-722.
|
| 7 |
Zheng JL, Lu L, Hu J, et al. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease [J]. Atherosclerosis, 2010, 210(2): 590-595.
|
| 8 |
Hattori N, Oda S, Sadahiro T, et al. YKL-40 identified by proteomic analysis as a biomarker of sepsis [J]. Shock, 2009, 32(4): 393-400.
|
| 9 |
Rathcke CN, Vestergaard H. YKL-40--an emerging biomarker in cardiovascular disease and diabetes [J]. Cardiovasc Diabetol, 2009, 8: 61.
|
| 10 |
Nordenbaek C, Johansen JS, Junker P, et al. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization [J]. J Infect Dis, 1999, 180(5): 1722-1726.
|
| 11 |
Wang HL, Hsiao PC, Tsai HT, et al. Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients [J]. Int J Mol Sci, 2013, 14(11): 22817-22825.
|
| 12 |
Spoorenberg SM, Vestjens SM, Rijkers GT, et al. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia [J]. Respirology, 2017, 22(3): 542-550.
|
| 13 |
Spoorenberg SMC, Vestjens SMT, Voorn GP, et al. Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis [J]. PLoS One, 2018, 13(1): e0190575.
|
| 14 |
Jang YY, Park HJ, Chung HL. Serum YKL-40 levels may help distinguish exacerbation of post-infectious bronchiolitis obliterans from acute bronchiolitis in young children [J]. Eur J Pediatr, 2017, 176(7): 971-978.
|
| 15 |
Yang X, Sheng G. YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children [J]. BMC Pediatr, 2018, 18(1): 381.
|
| 16 |
Sawatzky J, Soo J, Conroy AL, et al. Biomarkers of systemic inflammation in ugandan infants and children hospitalized with respiratory syncytial virus infection [J]. Pediatr Infect Dis J, 2019, 38(8): 854-859.
|
| 17 |
Fantino E, Gangell CL, Hartl D, et al. Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease [J]. BMC Pulm Med, 2014, 14: 28.
|
| 18 |
Johansen JS, Krabbe KS, Møller K, et al. Circulating YKL-40 levels during human endotoxaemia [J]. Clin Exp Immunol, 2005, 140(2): 343-348.
|
| 19 |
Kronborg G, Ostergaard C, Weis N, et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease [J]. Scand J Infect Dis, 2002, 34(5): 323-326.
|
| 20 |
Kornblit B, Hellemann D, Munthe-Fog L, et al. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts [J]. Immunobiology, 2013, 218(10): 1227-1234.
|
| 21 |
Maddens B, Ghesquière B, Vanholder R, et al. Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury [J]. Mol Cell Proteomics, 2012, 11(6): M111.013094.
|
| 22 |
Kim HH, Chung MH, Bin JH, et al. Urinary YKL-40 as a candidate biomarker for febrile urinary tract infection in young children [J]. Ann Lab Med, 2018, 38(1): 39-45.
|
| 23 |
Østergaard C, Johansen JS, Benfield T, et al. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis [J]. Clin Diagn Lab Immunol, 2002, 9(3): 598-604.
|
| 24 |
Erturk A, Cure E, Cure MC, et al. The association between serum YKL-40 levels, mean platelet volume, and c-reactive protein in patients with cellulitis [J]. Indian J Med Microbiol, 2015, 33(Suppl): 61-66.
|
| 25 |
Kjaergaard AD, Helby J, Johansen JS, et al. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population [J]. Clin Microbiol Infect, 2020, 26(10): 1411.e1-1411.e9.
|
| 26 |
Karwelat D, Schmeck B, Ringel M, et al. Influenza virus-mediated suppression of bronchial Chitinase-3-like 1 secretion promotes secondary pneumococcal infection [J]. FASEB J, 2020, 34(12): 16432-16448.
|
| 27 |
Gao N, Yu FS. Chitinase 3-like 1 promotes candida albicans killing and preserves corneal structure and function by controlling host antifungal responses [J]. Infect Immun, 2015, 83(10): 4154-4164.
|
| 28 |
黄丽林, 张静, 高文超, 等. 类几丁质酶3蛋白1在申克孢子丝菌刺激巨噬细胞的表达和作用研究 [J]. 中国人兽共患病学报, 2015, 31(10): 938-942.
|
| 29 |
Mizoguchi E. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells [J]. Gastroenterology, 2006, 130(2): 398-411.
|
| 30 |
Kawada M, Chen CC, Arihiro A, et al. Chitinase 3-like-1 enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin-binding protein [J]. Lab Invest, 2008, 88(8): 883-895.
|
| 31 |
Chen CC, Llado V, Eurich K, et al. Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells [J]. Clin Immunol, 2011, 140(3): 268-275.
|
| 32 |
Low D, Tran HT, Lee IA, et al. Chitin-binding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis [J]. Gastroenterology, 2013, 145(3): 602-612.e619.
|
| 33 |
Tran HT, Lee IA, Low D, et al. Chitinase 3-like 1 synergistically activates IL6-mediated STAT3 phosphorylation in intestinal epithelial cells in murine models of infectious colitis [J]. Inflamm Bowel Dis, 2014, 20(5): 835-846.
|
| 34 |
Bohr S, Patel SJ, Vasko R, et al. The role of CHI3L1 (Chitinase-3-like-1) in the pathogenesis of infections in burns in a mouse model [J]. PLoS One, 2015, 10(11): e0140440.
|
| 35 |
Zhang JJ, Zhang N, Wu W, et al. MicroRNA-24 modulates Staphylococcus aureus-induced macrophage polarization by suppressing CHI3L1 [J]. Inflammation, 2017, 40(3): 995-1005.
|
| 36 |
Chen X, Jiao J, He X, et al. CHI3L1 regulation of inflammation and the effects on osteogenesis in a Staphylococcus aureus-induced murine model of osteomyelitis [J]. FEBS J, 2017, 284(11): 1738-1747.
|
| 37 |
Kim MJ, Shim DH, Cha HR, et al. Chitinase 3-like 1 protein plays a critical role in respiratory syncytial virus-induced airway inflammation [J]. Allergy, 2019, 74(4): 685-697.
|
| 38 |
Li F, Sheng Z, Lan H, et al. Downregulated CHI3L1 alleviates skeletal muscle stem cell injury in a mouse model of sepsis [J]. IUBMB Life, 2020, 72(2): 214-225.
|